Direct Medical Costs of COVID-19 Infection Are Considerable
Costs could vary from $163.4 to $654.0 billion for 20 to 80 percent of U.S. population infected, respectively
Recommendations Issued for Imaging Use in Pediatric COVID-19
Recommendations applicable for mild COVID-19, moderate-severe COVID-19 with, without resource constraints
Roadmap Developed for Resuming Elective Surgery During COVID-19
Sustained drop in rate of new COVID-19 cases for at least 14 days required to resume elective surgery
Neurologic Features Tied to ARDS in Severe COVID-19 Described
Unclear whether critical illness, medication, infection itself may cause encephalopathy, agitation, confusion
Survey Finds Anesthesiologists Prepared for COVID-19 Patients
Authors say easy-to-understand algorithms, training for anesthesiologists could improve safety
COVID-19 Outcomes Worse With Diabetes, Hyperglycemia
Length of stay longer, mortality higher for those with diabetes and/or acutely uncontrolled hyperglycemia
Infection Rate Up Prior to Detection of Malignant Cancer
Increased odds of influenza, gastroenteritis, hepatitis, pneumonia seen one year before detection
COVID-19-Linked Changes Reported in Rheumatic Disease Patient Care
Forty-two percent of patients report change in care in previous two weeks
COVID-19 Pandemic Delays FDA Review of Vaping Products
Federal court has granted FDA request to delay May 12 deadline to Sept. 9
Premature Posting of Remdesivir Findings Were ‘Inconclusive’
Due to low enrollment, study was 'underpowered to enable statistically meaningful conclusions'
